Dr. R.L. Hamers publications

foto

Publications Dr. R.L. Hamers

Position
Postdoc
Main activities
Patient care, Research
Specialisation
internal medicine and infectious diseases
Focus of research

HIV treatment in resource-limited settings, in particular antiretroviral drug resistance and chronic immune dysregulation

2018

  • Gupta RK, Gregson J, Parkin N, Haile-Selassie H, Tanuri A, Andrade Forero L, Kaleebu P, Watera C, Aghokeng A, Mutenda N, Dzangare J, Hone S, Hang ZZ, Garcia J, Garcia Z, Marchorro P, Beteta E, Giron A, Hamers R, Inzaule S, Frenkel LM, Chung MH, de Oliveira T, Pillay D, Naidoo K, Kharsany A, Kugathasan R, Cutino T, Hunt G, Avila Rios S, Doherty M, Jordan MR, Bertagnolio S, HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis. LANCET INFECT DIS 2018;18 (3):346-355 [PubMed]
  • Hamers RL, Rinke de Wit TF, Holmes CB, HIV drug resistance in low-income and middle-income countries. LANCET HIV 2018;5 (10):e588-e596 [PubMed]
  • Hemelaar J, Elangovan R, Yun J, Dickson-Tetteh L, Fleminger I, Kirtley S, Williams B, Gouws-Williams E, Ghys PD [Contributors: Abimiku AlG, Agwale S, Archibald C, Avidor B, Barbás MG, Barre-Sinoussi F, Barugahare B, Belabbes EH, Bertagnolio S, Birx D, Bobkov AF, Brandful J, Bredell H, Brennan CA, Brooks J, Bruckova M, Buonaguro L, Buonaguro F, Buttò S, Buve A, Campbell M, Carr J, Carrera A, Carrillo MG, Celum C, Chaplin B, Charles M, Chatzidimitriou D, Chen Z, Chijiwa K, Cooper D, Cunningham P, Dagnra A, de Gascun CF, del Amo J, Delgado E, Dietrich U, Dwyer D, Ellenberger D, Ensoli B, Essex M, Gao F, Fleury H, Fonjungo PN, Foulongne V, Gadkari DA, García F, Garsia R, Gershy-Damet GM, Glynn JR, Goodall R, Grossman Z, Lindenmeyer-Guimarães M, Hahn B, Hamers RL, Hamouda O, Handema R, He X, Herbeck J, Ho DD, Holguin A, Hosseinipour M, Hunt G, Ito M, Bel Hadj Kacem MA, Kahle E, Kaleebu PK, Kalish M, Kamarulzaman A, Kang C, Kanki P, Karamov E, Karasi JC, Kayitenkore K, Kelleher T, Kitayaporn D, Kostrikis LG, Kucherer C, Lara C, Leitner T, Liitsola K, Lingappa J, Linka M, Lorenzana de Rivera I, Lukashov V, Maayan S, Mayr L, McCutchan F, Meda N, Menu E, Mhalu F, Mloka D, Mokili JL, Montes B, Mor O, Morgado M, Mosha F, Moussi A, Mullins J, Najera R, Nasr M, Ndembi N, Neilson JR, Nerurkar VR, Neuhann F, Nolte C, Novitsky V, Nyambi P, Ofner M, Paladin FJ, Papa A, Pape J, Parkin N, Parry C, Peeters M, Pelletier A, Pérez-Álvarez L, Pillay D, Pinto A, Quang TD, Rademeyer C, Raikanikoda F, Rayfield MA, Reynes JM, Rinke de Wit T, Robbins KE, Rolland M, Rousseau C, Salazar-Gonzales J, Salem H, Salminen M, Salomon H, Sandstrom P, Santiago ML, Sarr AD, Schroeder B, Segondy M, Selhorst P, Sempala S, Servais J, Shaik A, Shao Y, Slim A, Soares MA, Songok E, Stewart D, Stokes J, Subbarao S, Sutthent R, Takehisa J, Tanuri A, tee KK, Thapa K, Thomson M, Tran T, Urassa W, Ushijima H, van de Perre P, van der Groen G, van Laethem K, van Oosterhout J, van Sighem A, van Wijngaerden E, Vandamme AM, Vercauteren J, Vidal N, Wallace L, Williamson C, Wolday D, Xu J, Yang C, Zhang L, Zhang R]] , Global and regional molecular epidemiology of HIV-1, 1990-2015: a systematic review, global survey, and trend analysis. LANCET INFECT DIS 2018;ahead of print [PubMed]
  • Inzaule SC, Hamers RL, Calis J , Boerma R, Sigaloff K, Zeh C, Mugyenyi P, Akanmu S, Rinke de Wit TF, When prevention of mother-to-child HIV transmission fails: preventing pretreatment drug resistance in African children. AIDS 2018;32 (2):143-147 [PubMed]
  • Inzaule SC, Hamers RL, Noguera-Julian M, Casadellà M, Parera M, Kityo C, Steegen K, Naniche D, Clotet B, Rinke de Wit TF, Paredes R [Contributors: Osibogun A, Wallis CL, Nalubwama C, Letsoalo E, Senono F, Adelabu H, Kakooza H, Namata H, Sanne I, Nankya I, Menke J, Lange JMA, Sigaloff KCE, Mandaliya K, Hardman M, Siwale M, de Jager M, Dolan M, Botes ME, O'Mello M, Wellington M, Mutebi M, Nakitto M, Labib M, Pakker N, Ondoa P, Mugyenyi P, Ive P, Nakanjako R, Schuurman R, Lüthy R, Balinda SN, Akanmu S, Boender TS, Adeyemo TA, Rodoye T, Stevens WS, Namala W]] , Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. LANCET HIV 2018;5 (11):e638-e646 [PubMed]
  • Inzaule SC, Hamers RL, Noguera-Julian M, Casadellà M, Parera M, Rinke de Wit TF, Paredes R, Primary resistance to integrase strand transfer inhibitors in patients infected with diverse HIV-1 subtypes in sub-Saharan Africa. J ANTIMICROB CHEMOTH 2018;73 (5):1167-1172 [PubMed]
  • Inzaule SC, Kityo CM, Siwale M, Akanmu AS, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, Boender TS, Ondoa P, Sigaloff KCE, Naniche D, Rinke de Wit TF, Hamers RL, Previous antiretroviral drug use compromises standard first-line HIV therapy and is mediated through drug-resistance. SCI REP-UK 2018;8 (1):15751 [PubMed]
  • Inzaule SC, Rinke de Wit TF, Hamers RL, Does tenofovir-containing first-line ART mitigate the impact of pretreatment NNRTI drug resistance?. CLIN INFECT DIS 2018;ahead of print [PubMed]
  • Inzaule SC, Rinke de Wit TF, Hamers RL, HIV Drug Resistance. NEW ENGL J MED 2018;378 (9):873-874 [PubMed]
  • Kroeze S, Ondoa P, Kityo CM, Siwale M, Akanmu S, Wellington M, de Jager M, Ive P, Mandaliya K, Stevens W, Boender TS, de Pundert ME, Sigaloff KCE, Reiss P, Wit FWNM, Rinke de Wit TF, Hamers RL, Suboptimal immune recovery during antiretroviral therapy with sustained HIV suppression in sub-Saharan Africa. AIDS 2018;32 (8):1043-1051 [PubMed]
  • Revell AD, Wang D, Perez-Elias MJ, Wood R, Cogill D, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Rehm CA, Pozniak A, Montaner JSG, Lane HC, Larder BA [Contributors: Reiss P, van Sighem A, Montaner J, Harrigan R, Rinke de Wit T, Hamers R, Sigaloff K, Agan B, Marconi V, Wegner S, Sugiura W, Zazzi M, Kaiser R, Schuelter E, Streinu-Cercel A, Alvarez-Uria G, Perez-Elias MJ, de Oliveira T, Gatell J, Lazzari E, Gazzard B, Nelson M, Pozniak A, Mandalia S, Smith C, Ruiz L, Clotet B, Staszewski S, Torti C, Lane C, Metcalf J, Rehm CA, Vella S, Dettorre G, Carr A, Norris R, Hesse K, Vlahakis E, Tempelman H, Barth R, Wood R, Morrow C, Cogill D, Hoffmann C, Ene L, Dragovic G, Diaz R, Sucupira C, Sued O, Cesar C, Madero JS, Balavskrishnan P, Saravanan S, Emery S, Cooper D, Baxter J, Monno L, Clotet B, Picchio G, Debethune MP, Khabo P, Ledwaba L]] , 2018 update to the HIV-TRePS system: the development of new computational models to predict HIV treatment outcomes, with or without a genotype, with enhanced usability for low-income settings. J ANTIMICROB CHEMOTH 2018;73 (8):2186-2196 [PubMed]

2017

  • Bijker R, Jiamsakul A, Kityo C, Kiertiburanakul S, Siwale M, Phanuphak P, Akanmu S, Chaiwarith R, Wit FW, Sim BL, Boender TS, Ditangco R, Rinke de Wit TF, Sohn AH, Hamers RL, Adherence to antiretroviral therapy for HIV in sub-Saharan Africa and Asia: a comparative analysis of two regional cohorts. J INT AIDS SOC 2017;20 (1):1-10 [PubMed]
  • Gregson J, Kaleebu P, Marconi VC, van Vuuren C, Ndembi N, Hamers RL, Kanki P, Hoffmann CJ, Lockman S, Pillay D, de Oliveira T, Clumeck N, Hunt G, Kerschberger B, Shafer RW, Yang C, Raizes E, Kantor R, Gupta RK, Occult HIV-1 drug resistance to thymidine analogues following failure of first-line tenofovir combined with a cytosine analogue and nevirapine or efavirenz in sub Saharan Africa: a retrospective multi-centre cohort study. LANCET INFECT DIS 2017;17 (3):296-304 [PubMed]
  • Inzaule SC, Hamers RL, Kityo C, Rinke de Wit TF, Roura M, Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study (vol 11, e0167492, 2016). PLOS ONE 2017;12 (2):e0172077 [PubMed]
  • Inzaule SC, Hamers RL, Mukui I, Were K, Owiti P, Kwaro D, Rinke de Wit TF, Zeh C, Emergence of untreatable, multidrug-resistant HIV-1 in patients failing second-line therapy in Kenya. AIDS 2017;31 (10):1495-1498 [PubMed]
  • Paredes R, Tzou PL, van Zyl G, Barrow G, Camacho R, Carmona S, Grant PM, Gupta RK, Hamers RL, Harrigan PR, Jordan MR, Kantor R, Katzenstein DA, Kuritzkes DR, Maldarelli F, Otelea D, Wallis CL, Schapiro JM, Shafer RW, Collaborative update of a rule-based expert system for HIV-1 genotypic resistance test interpretation. PLOS ONE 2017;12 (7):e0181357 [PubMed]
  • Rhee SY, Varghese V, Holmes SP, van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MAA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW, Mutational Correlates of Virological Failure in Individuals Receiving a WHO-Recommended Tenofovir-Containing First-Line Regimen: An International Collaboration. EBIOMEDICINE 2017;18:225-235 [PubMed]

2016

  • Boender TS, Hamers RL, Ondoa P, Wellington M, Chimbetete C, Siwale M, Labib Maksimos EEF, Balinda SN, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Stevens W, Rinke de Wit TF, Sigaloff KCE, Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. J INFECT DIS 2016;214 (6):873-883 [PubMed]
  • Boender TS, Kityo CM, Boerma RS, Hamers RL, Ondoa P, Wellington M, Siwale M, Nankya I, Kaudha E, Akanmu AS, Botes ME, Steegen K, Calis JCJ, Rinke de Wit TF, Sigaloff KCE, Accumulation of HIV-1 drug resistance after continued virological failure on first-line ART in adults and children in sub-Saharan Africa. J ANTIMICROB CHEMOTH 2016;71 (10):2918-2927 [PubMed]
  • Gregson J, Tang M, Ndembi N, Hamers RL, Rhee SY, Marconi VC, Diero L, Brooks K, Theys K, de Wit TFR, Arruda M, Garcia F, Monge S, Gunthard HF, Hoffmann CJ, Kanki PJ, Kumarasamy N, Kerschberger B, Mor O, Charpentier C, Todesco E, Rokx C, Gras L, Halvas EK, Sunpath H, Di Carlo D, Antinori A, Andreoni M, Latini A, Mussini C, Aghokeng A, Sonnerborg A, Neogi U, Fessel WJ, Agolory S, Yang C, Blanco JL, Juma JM, Smit E, Schmidt D, Watera C, Asio J, Kirungi W, Tostevin A, El-Hay T, Clumeck N, Goedhals D, van Vuuren C, Bester PA, Sabin C, Mukui I, Santoro MM, Perno CF, Hunt G, Morris L, Camacho R, de Oliveira T, Pillay D, Schulter E, Murakami-Ogasawara A, Reyes-Teran G, Romero K, Avila-Rios S, Sirivichayakul S, Ruxrungtham K, Mekprasan S, Dunn D, Kaleebu P, Raizes E, Kantor R, Shafer RW, Gupta RK, Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study. LANCET INFECT DIS 2016;16 (5):565-575
  • Grijsen ML, Kaderbhai HS, Hamers RL, Masenga JE, Onder vuur in Tanzania. NED TIJDSCHR DERMATOL VENEREOL 2016;26 (9):538-541
  • Hamers RL, Enhancement of clinical decision making in HIV care in Africa. LANCET HIV 2016;3 (2):e59-e60 [PubMed]
  • Hamers RL, Paredes R, Next-generation sequencing and HIV drug resistance surveillance. LANCET HIV 2016;3 (12):e553-e554 [PubMed]
  • Hamers RL, van Gool T, Goorhuis A, Benznidazole for Chronic Chagas' Cardiomyopathy. NEW ENGL J MED 2016;374 (2):188 [PubMed]
  • Inzaule SC, Hamers RL, Kityo C, Rinke de Wit TF, Roura M, Long-Term Antiretroviral Treatment Adherence in HIV-Infected Adolescents and Adults in Uganda: A Qualitative Study. PLOS ONE 2016;11 (11):e0167492 [PubMed]
  • Inzaule SC, Hamers RL, Zeh CE, Rinke de Wit TF, Stringent HIV Viral Load Threshold for Virological Failure Using Dried Blood Spots: Is the Perfect the Enemy of the Good?. JAIDS-J ACQ IMM DEF 2016;71 (1):e30-e33 [PubMed]
  • Inzaule SC, Ondoa P, Peter T, Mugyenyi PN, Stevens WS, Rinke de Wit TF, Hamers RL, Affordable HIV drug-resistance testing for monitoring of antiretroviral therapy in sub-Saharan Africa. LANCET INFECT DIS 2016;16 (11):e267-e275 [PubMed]
  • Inzaule SC, Weidle PJ, Yang C, Ndiege K, Hamers RL, Rinke de Wit TF, Thomas T, Zeh C, Prevalence and dynamics of the K65R drug resistance mutation in HIV-1-infected infants exposed to maternal therapy with lamivudine, zidovudine and either nevirapine or nelfinavir in breast milk. J ANTIMICROB CHEMOTH 2016;71 (6):1619-1626 [PubMed]
  • Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem AI, Nelson M, Montaner JSG, Lane HC, Larder BA [Contributors: Reiss P, van Sighem A, Montaner J, Harrigan R, de Wit TR, Hamers R, Sigaloff K, Agan B, Marconi V, Wegner S, Sugiura W, Zazzi M, Kaiser R, Schuelter E, Streinu-Cercel A, Alvarez-Uria G, Gatell J, Lazzari E, Gazzard B, Nelson M, Pozniak A, Mandalia S, Webster D, Smith C, Ruiz L, Clotet B, Staszewski S, Torti C, Lane C, Metcalf J, Perez-Elias MJ, Vella S, Dettorre G, Carr A, Norris R, Hesse K, Vlahakis E, Tempelman H, Barth R, Morrow C, Wood R, Hoffmann C, Ene L, Dragovic G, Diaz R, Sucupira C, Sued O, Cesar C, Madero JS, Emery S, Cooper D, Baxter J, Monno L, Clotet B, Picchio G, Debethune MP, Khabo P, Ledwaba L]] , An update to the HIV-TRePS system: the development and evaluation of new global and local computational models to predict HIV treatment outcomes, with or without a genotype. J ANTIMICROB CHEMOTH 2016;71 (10):2928-2937 [PubMed]
  • Revell A, Khabo P, Ledwaba L, Emery S, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Reiss P, van Sighem A, Pozniak A, Montaner J, Lane HC, Larder B, Computational models as predictors of HIV treatment outcomes for the Phidisa cohort in South Africa. S AFR J HIV MED 2016;17 (1):450

2015

  • Boender TS, Hoenderboom BM, Sigaloff KCE, Hamers RL, Wellington M, Shamu T, Siwale M, Labib Maksimos EEF, Nankya I, Kityo CM, Adeyemo TA, Akanmu AS, Mandaliya K, Botes ME, Ondoa P, Rinke de Wit TF, Pretreatment HIV drug resistance increases regimen switches in sub-Saharan Africa. CLIN INFECT DIS 2015;61 (11):1749-1758 [PubMed]
  • Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, Rinke de Wit TF, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, de Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW, Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis. PLOS MED 2015;12 (4):e1001810 [PubMed]
  • Rhee SY, Jordan MR, Raizes E, Chua A, Parkin N, Kantor R, van Zyl GU, Mukui I, Hosseinipour MC, Frenkel LM, Ndembi N, Hamers RL, Rinke de Wit TF, Wallis CL, Gupta RK, Fokam J, Zeh C, Schapiro JM, Carmona S, Katzenstein D, Tang M, Aghokeng AF, de Oliveira T, Wensing AMJ, Gallant JE, Wainberg MA, Richman DD, Fitzgibbon JE, Schito M, Bertagnolio S, Yang C, Shafer RW, HIV-1 Drug Resistance Mutations: Potential Applications for Point-of-Care Genotypic Resistance Testing. PLOS ONE 2015;10 (12):e0145772 [PubMed]

2014

  • Bezemer D, Faria NR, Hassan A, Hamers RL, Mutua G, Anzala O, Mandaliya K, Cane P, Berkley JA, Rinke de Wit TF, Wallis C, Graham SM, Price MA, Coutinho RA, Sanders EJ, HIV Type 1 transmission networks among men having sex with men and heterosexuals in Kenya. AIDS RES HUM RETROV 2014;30 (2):118-126 [PubMed]
  • Nichols BE, Sigaloff KCE, Kityo C, Hamers RL, Baltussen R, Bertagnolio S, Jordan MR, Hallett TB, Boucher CAB, de Wit TFR, van de Vijver DAMC, Increasing the use of second-line therapy is a cost-effective approach to prevent the spread of drug-resistant HIV: a mathematical modelling study. J INT AIDS SOC 2014;17 (1):19164 [PubMed]
  • Nichols BE, Sigaloff KCE, Kityo C, Mandaliya K, Hamers RL, Bertagnolio S, Jordan MR, Boucher CAB, Rinke de Wit TF, van de Vijver DAMC, Averted HIV infections due to expanded antiretroviral treatment eligibility offsets risk of transmitted drug resistance: a modeling study. AIDS 2014;28 (1):73-83 [PubMed]
  • Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers R, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing A, Reiss P, van Sighem AI, Nelson M, Emery S, Montaner JSG, Lane HC, Larder BA [Contributors: Reiss P, van Sighem A, Montaner J, Harrigan R, Rinke de Wit T, Hamers R, Sigaloff K, Agan B, Marconi V, Wegner S, Sugiura W, Zazzi M, Streinu-Cercel A, Alvarez-Uria G, Gatell J, Lazzari E, Gazzard B, Nelson M, Pozniak A, Mandalia S, Ruiz L, Clotet B, Staszewski S, Torti C, Lane C, Metcalf J, Perez-Elias MJ, Carr A, Norris R, Hesse K, Vlahakis E, Tempelman H, Barth R, Morrow C, Wood R, Ene L, Dragovic G, Emery S, Cooper D, Baxter J, Monno L, Clotet B, Picchio G, Debethune MP]] , An update to the HIV-TRePS system: the development of new computational models that do not require a genotype to predict HIV treatment outcomes. J ANTIMICROB CHEMOTH 2014;69 (4):1104-1110 [PubMed]

2013

  • de Luca A, Hamers RL, Schapiro JM, Antiretroviral treatment sequencing strategies to overcome HIV type 1 drug resistance in adolescents and adults in low-middle-income countries. J INFECT DIS 2013;207 (Suppl. 2):S63-S69 [PubMed]
  • Hamers RL. Drug-resistant HIV-1 in sub-Saharan Africa. Clinical and public health studies. s.l: s.n.; 2013. 365p. ISBN 9789461693297 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Rinke de Wit TF, Mugyenyi P; copromotor(s): van Vugt M, Schuurman R)
  • Hamers RL, Kityo C, Sigaloff KCE, Rinke de Wit TF, Pretreatment HIV-1 drug resistance in Africa. LANCET INFECT DIS 2013;13 (6):476 [PubMed]
  • Hamers RL, Sigaloff KCE, Kityo C, Mugyenyi P, de Wit TFR, Emerging HIV-1 drug resistance after roll-out of antiretroviral therapy in sub-Saharan Africa. CURR OPIN HIV AIDS 2013;8 (1):19-26 [PubMed]
  • Hamers RL, Sigaloff KCE, Kityo C, Mugyenyi P, Rinke de Wit TF, HIV-1 drug resistance in antiretroviral-naive patients in sub-Saharan Africa. LANCET INFECT DIS 2013;13 (3):196-197 [PubMed]
  • Hamers RL, Zaaijer HL, Wallis CL, Siwale M, Ive P, Botes ME, Sigaloff KCE, Hoepelman AIM, Stevens WS, Rinke de Wit TF, HIV-HBV coinfection in Southern Africa and the effect of lamivudine- versus tenofovir-containing cART on HBV outcomes. JAIDS-J ACQ IMM DEF 2013;64 (2):174-182 [PubMed]
  • Revell AD, Wang D, Wood R, Morrow C, Tempelman H, Hamers RL, Alvarez-Uria G, Streinu-Cercel A, Ene L, Wensing AMJ, DeWolf F, Nelson M, Montaner JS, Lane HC, Larder BA, Computational models can predict response to HIV therapy without a genotype and may reduce treatment failure in different resource-limited settings. J ANTIMICROB CHEMOTH 2013;68 (6):1406-1414 [PubMed]
  • Sigaloff KCE, Kayiwa J, Musiime V, Calis JCJ, Kaudha E, Mukuye A, Matama C, Nankya I, Nakatudde L, Dekker JT, Hamers RL, Mugyenyi P, Rinke de Wit TF, Kityo C, Short communication: high rates of thymidine analogue mutations and dual-class resistance among HIV-infected Ugandan children failing first-line antiretroviral therapy. AIDS RES HUM RETROV 2013;29 (6):925-930 [PubMed]
  • Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, Rinke de Wit TF, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW, Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine. J INFECT DIS 2013;207 (Suppl. 2):S70-S77 [PubMed]

2012

  • Boender TS, Sigaloff KCE, Kayiwa J, Musiime V, Calis JCJ, Hamers RL, Nakatudde LK, Khauda E, Mukuye A, Ditai J, Geelen SP, Mugyenyi P, Rinke de Wit TF, Kityo C, Barriers to Initiation of Pediatric HIV Treatment in Uganda: A Mixed-Method Study. AIDS RES TREAT 2012;2012:817506 [PubMed]
  • Gupta RK, Jordan MR, Sultan BJ, Hill A, Davis DHJ, Gregson J, Sawyer AW, Hamers RL, Ndembi N, Pillay D, Bertagnolio S, Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis. LANCET 2012;380 (9849):1250-1258 [PubMed]
  • Hamers RL, Kityo C, Lange JMA, de Wit TFR, Mugyenyi P, Global threat from drug resistant HIV in sub-Saharan Africa. BMJ-BRIT MED J 2012;344:e4159 [PubMed]
  • Hamers RL, Oyomopito R, Kityo C, Phanuphak P, Siwale M, Sungkanuparph S, Conradie F, Kumarasamy N, Botes ME, Sirisanthana T, Abdallah S, Li PCK, Ngorima N, Kantipong P, Osibogun A, Lee CKC, Stevens WS, Kamarulzaman A, Derdelinckx I, Chen YMA, Schuurman R, van Vugt M, Rinke de Wit TF [Contributors: Njovu C, Labib M, Menke J, Botes ME, Conradie F, Sanne I, Wallis CL, Stevens WS, Hardman M, Ngorima N, Wellington M, Luthy R, Mandaliya K, Abdallah S, Jao I, Dolan M, Kityo C, Namayanja G, Nakatudde L, Kiconco M, Abwola M, Mugyenyi P, Kaleebu P, Osibogun A, Akanmu S, Wensing AM, Derdelinckx I, Schuurman R, Hamers RL, Sigaloff K, Straatsma E, van Vugt M, Rinke de Wit TF, Li PCK, Lee MP, Wong KH, Kumarasamy N, Saghayam S, Pujari S, Joshi K, Merati TP, Yuliana F, Lee CKC, Low LL, Kamarulzaman A, Ong LY, Mustafa M, Nordin N, Ditangco R, Bantique RO, Chen YMA, Wong WW, Yang YW, Phanuphak P, Sirivichayakul S, Sungkanuparph S, Piyavong B, Sirisanthana T, Praparattanapan J, Kantipong P, Kambua P, Choi JY, Han SH, Ratanasuwan W, Sriondee R, Kantor R, Sohn AH, Messerschmidt L, Singtoroj T, Cooper DA, Law MG, Jiamsakul A, Zhou J]] , Cohort Profile: The PharmAccess African (PASER-M) and the TREAT Asia (TASER-M) Monitoring Studies to Evaluate Resistance-HIV drug resistance in sub-Saharan Africa and the Asia-Pacific. INT J EPIDEMIOL 2012;41 (1):43-54 [PubMed]
  • Hamers RL, Sawyer AW, Tuohy M, Stevens WS, Rinke de Wit TF, Hill AM, Cost-effectiveness of laboratory monitoring for management of HIV treatment in sub-Saharan Africa: a model-based analysis. AIDS 2012;26 (13):1663-1672 [PubMed]
  • Hamers RL, Schuurman R, Sigaloff KCE, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Wit FW, van Vugt M, Stevens WS, de Wit TFR, Effect of pretreatment HIV-1 drug resistance on immunological, virological, and drug-resistance outcomes of first-line antiretroviral treatment in sub-Saharan Africa: a multicentre cohort study. LANCET INFECT DIS 2012;12 (4):307-317 [PubMed]
  • Hamers RL, Sigaloff KCE, Wensing AM, Wallis CL, Kityo C, Siwale M, Mandaliya K, Ive P, Botes ME, Wellington M, Osibogun A, Stevens WS, Rinke de Wit TF, Schuurman R [Contributors: Siwale M, Njovu C, Labib M, Menke J, Botes ME, Conradie F, Ive P, Sanne I, Wallis CL, Letsoalo E, Stevens WS, Hardman M, Wellington M, Luthy R, Mandaliya K, Abdallah S, Jao I, Dolan M, Kityo C, Namayanja G, Nakatudde L, Nankya I, Kiconco M, Abwola M, Mugyenyi P, Osibogun A, Akanmu S, Schuurman R, Wensing AM, Hamers RL, Sigaloff KCE, Straatsma E, Wit FW, Dekker J, van Vugt M, Lange JM, Rinke de Wit TF]] , Patterns of HIV-1 Drug Resistance After First-Line Antiretroviral Therapy (ART) Failure in 6 Sub-Saharan African Countries: Implications for Second-Line ART Strategies. CLIN INFECT DIS 2012;54 (11):1660-1669 [PubMed]
  • Hamers RL, Straatsma E, Kityo C, Wallis CL, Stevens WS, Sigaloff KCE, Siwale M, Conradie F, Botes ME, Mandaliya K, Wellington M, Osibogun A, van Vugt M, Rinke de Wit TF, Building Capacity for the Assessment of HIV Drug Resistance: Experiences From the PharmAccess African Studies to Evaluate Resistance Network. CLIN INFECT DIS 2012;54 (4):S261-S265 [PubMed]
  • Sigaloff KCE, Hamers RL, Menke J, Labib M, Siwale M, Ive P, Botes ME, Kityo C, Mandaliya K, Wellington M, Osibogun A, Geskus RB, Stevens WS, van Vugt M, Rinke de Wit TF, Early Warning Indicators for Population-Based Monitoring of HIV Drug Resistance in 6 African Countries. CLIN INFECT DIS 2012;54 (4):S294-S299 [PubMed]
  • Sigaloff KCE, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, Botes ME, Mandaliya K, Wellington M, Osibogun A, Stevens WS, van Vugt M, Rinke de Wit TF, Second-Line Antiretroviral Treatment Successfully Resuppresses Drug-Resistant HIV-1 After First-Line Failure: Prospective Cohort in Sub-Saharan Africa. J INFECT DIS 2012;205 (11):1739-1744 [PubMed]
  • Sigaloff KCE, Mandaliya K, Hamers RL, Otieno F, Jao IM, Lyagoba F, Magambo B, Kapaata A, Ndembi N, Rinke de Wit TF, Short Communication High Prevalence of Transmitted Antiretroviral Drug Resistance Among Newly HIV Type 1 Diagnosed Adults in Mombasa, Kenya. AIDS RES HUM RETROV 2012;28 (9):833-837 [PubMed]

2011

  • Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, Botes ME, Wellington M, Osibogun A, Sigaloff KCE, Nankya I, Schuurman R, Wit FW, Stevens WS, van Vugt M, de Wit TFR [Contributors: Mandaliya K, Abdallah S, Jao I, Dolan M, Schuurman R, Wensing AM, Hamers RL, Sigaloff KCE, Straatsma E, Wit FW, van Vugt M, Lange JM, Rinke de Wit TF, Osibogun A, Akanmu S, Botes ME, Conradie F, Ive P, Sanne I, Wallis CL, Letsoalo E, Stevens WS, Hardman M, Kityo C, Namayanja G, Nakatudde L, Nankya I, Kiconco M, Abwola M, Mugyenyi P, Ndembi N, Lyagoba F, Kaleebu P, Siwale M, Njovu C, Labib M, Menke J, Wellington M, Luthy R]] , HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. LANCET INFECT DIS 2011;11 (10):750-759 [PubMed]
  • Hamers RL, Wensing AMJ, Back NKT, Arcilla MS, Frissen JPH, Multi-nucleoside reverse transcriptase inhibitor resistant HIV type-1 in a patient from Sierra Leone failing stavudine, lamivudine and nevirapine. ANTIVIR THER 2011;16 (1):115-118 [PubMed]
  • Ndembi N, Hamers RL, Sigaloff KCE, Lyagoba F, Magambo B, Nanteza B, Watera C, Kaleebu P, Rinke de Wit TF, Transmitted antiretroviral drug resistance among newly HIV-1 diagnosed young individuals in Kampala. AIDS 2011;25 (7):905-910 [PubMed]
  • Sigaloff KCE, Hamers RL, Wallis CL, Kityo C, Siwale M, Ive P, Botes ME, Mandaliya K, Wellington M, Osibogun A, Stevens WS, van Vugt M, Rinke de Wit TF, Unnecessary Antiretroviral Treatment Switches and Accumulation of HIV Resistance Mutations; Two Arguments for Viral Load Monitoring in Africa. JAIDS-J ACQ IMM DEF 2011;58 (1):23-31 [PubMed]
  • Welzen MEB, van den Berk GEL, Hamers RL, Burger DM, Interaction between antiretroviral drugs and acenocoumarol. ANTIVIR THER 2011;16 (2):249-252 [PubMed]

2010

  • Hamers RL, Siwale M, Wallis CL, Labib M, van Hasselt R, Stevens WS, Schuurman R, Wensing AMJ, van Vugt M, Rinke de Wit TF, HIV-1 Drug Resistance Mutations Are Present in Six Percent of Persons Initiating Antiretroviral Therapy in Lusaka, Zambia. JAIDS-J ACQ IMM DEF 2010;55 (1):95-101 [PubMed]
  • Revell AD, Wang D, Harrigan R, Hamers RL, Wensing AMJ, DeWolf F, Nelson M, Geretti AM, Larder BA, Modelling response to HIV therapy without a genotype: an argument for viral load monitoring in resource-limited settings. J ANTIMICROB CHEMOTH 2010;65 (4):605-607 [PubMed]

2009

  • Hamers RL, de Beer I, Kaura H, van Vugt M, Rinke de Wit TF, Oral Fluid HIV Rapid Testing in Southern Africa Is Suitable for Population-Level Surveillance But May Not Be So for Individual Diagnosis (Invited Response to Scott et al: Can Oral Fluid Testing Be Used to Replace Blood-Based HIV Rapid Testing to Improve Access to Diagnosis in South Africa?). JAIDS-J ACQ IMM DEF 2009;51 (5):648-649 [PubMed]
  • Hamers RL, Smit PW, Stevens W, Schuurman R, Rinke de Wit TF, Dried fluid spots for HIV type-1 viral load and resistance genotyping: a systematic review. ANTIVIR THER 2009;14 (5):619-629 [PubMed]

2008

  • Hamers RL, de Beer IH, Kaura H, van Vugt M, Caparos L, Rinke de Wit TF, Diagnostic accuracy of 2 oral fluid-based tests for HIV surveillance in Namibia. JAIDS-J ACQ IMM DEF 2008;48 (1):116-118 [PubMed]
  • Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Chuurman R, The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa (vol 13, pg 625, 2008). ANTIVIR THER 2008;13 (8):1129
  • Hamers RL, Derdelinckx I, van Vugt M, Stevens W, Rinke de Wit TF, Schuurman R, The status of HIV-1 resistance to antiretroviral drugs in sub-Saharan Africa. ANTIVIR THER 2008;13 (5):625-639 [PubMed]

2007

  • Hamers RL, Schuurman R, van Vugt M, Derdelinckx I, Rinke de Wit TF, Aidsbehandeling in Afrika: het risico van antiretrovirale resistentie. NED TIJDSCHR GENEESKD 2007;151 (48):2666-2671 [PubMed]